J Wolter
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Cancer Risks and Factors
Papers in
- Oncology 14
- Cancer Treatment and Pharmacology 10
- HER2/EGFR in Cancer Research 3
- Cancer Diagnosis and Treatment 2
-
- Breast Cancer Treatment Studies 10
- Cancer Genomics and Diagnostics 2
- Co-authors
- Bernard Fisher (3 shared papers)Norman Wolmark (3 shared papers)Rafael Bornstein (2 shared papers)W. Eiermann (3 shared papers)Carl Blomqvist (1 shared paper)M. Azab (1 shared paper)Charles L. Vogel (1 shared paper)Stephen E. Jones (1 shared paper)
- Journals
- Journal of Clinical Oncology (8 papers)Cancer (1 paper)International Journal of Molecular Sciences (1 paper)Osteoporosis International (1 paper)Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (2 papers)
- Partner nations
- United StatesGermanySouth Africa
In The Last Decade
J Wolter
25 papers receiving 972 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 567
- Oncology 665
- Genetics 383
- Pulmonary and Respiratory Medicine 205
- Pathology and Forensic Medicine 104
Countries citing papers authored by J Wolter
This map shows the geographic impact of J Wolter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Wolter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Wolter more than expected).
Fields of papers citing papers by J Wolter
This network shows the impact of papers produced by J Wolter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Wolter. The network helps show where J Wolter may publish in the future.
Co-authors
The 25 scholars most cited alongside J Wolter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 299 | |
| 2 | 1997 | 240 | |
| 3 | 1986 | 162 | |
| 4 | 1995 | 47 | |
| 5 | Megestrol acetate used as primary hormonal therapy in stage D prostatic cancer. | 1985 | 29 |
| 6 | Acute toxicity during adjuvant chemotherapy for breast cancer: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience from 1717 patients receiving single and multiple agents. | 1981 | 28 |
| 7 | 1987 | 25 | |
| 8 | 1981 | 25 | |
| 9 | Phase II study of single-agent therapy with megestrol acetate, VP-16-213, cyclophosphamide, and dianhydrogalactitol in advanced renal cell cancer. | 1979 | 24 |
| 10 | 1994 | 22 | |
| 11 | 1991 | 21 | |
| 12 | Randomized trial of chlorpromazine, caffeine, and methyl-CCNU in disseminated melanoma. | 1980 | 18 |
| 13 | Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen. | 1988 | 15 |
| 14 | Tandem peripheral blood progenitor cell transplants as initial therapy for metastatic breast cancer. | 1995 | 13 |
| 15 | Phase II trial adriamycin and cis-dichlorodiammineplatinum(II) in squamous cell, ovarian, and testicular carcinomas. | 1978 | 11 |
| 16 | Megestrol acetate as primary hormonal therapy for advanced breast cancer. | 1988 | 10 |
| 17 | Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma. | 1978 | 9 |
| 18 | Phase II study of mitoxantrone, aclarubicin, and diaziquone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group study. | 1985 | 8 |
| 19 | Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial. | 1986 | 8 |
| 20 | 2004 | 6 |
About J Wolter
J Wolter is a scholar working on Oncology, Cancer Research, Genetics, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Breast Cancer Treatment Studies (10 papers), Estrogen and related hormone effects (6 papers), Cancer therapeutics and mechanisms (3 papers), HER2/EGFR in Cancer Research (3 papers), Economic and Financial Impacts of Cancer (2 papers), Cancer Genomics and Diagnostics (2 papers) and Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Cancer Research (567 citations), Oncology (665 citations), Genetics (383 citations), Pulmonary and Respiratory Medicine (205 citations) and Pathology and Forensic Medicine (104 citations). J Wolter has collaborated with scholars based in United States, Germany and South Africa. Frequent co-authors include Bernard Fisher, Norman Wolmark, Rafael Bornstein, W. Eiermann, Carl Blomqvist, M. Azab, Charles L. Vogel, Stephen E. Jones, W. Jonat and Anthony Howell. Their work appears in journals such as Journal of Clinical Oncology, Cancer, International Journal of Molecular Sciences, Osteoporosis International and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.